Target intelligence / Profile preview

Lipopolysaccharide core glycolipid and outer membrane proteins (LPS/OMP)

Target
LPS/OMP
Molecular classification
Bacterial cell envelope component, Glycolipid, Outer membrane protein
01

Overview

The outer membrane of Gram-negative bacteria is a specialized asymmetric bilayer where the outer leaflet is primarily composed of lipopolysaccharides (LPS) and the membrane is embedded with various outer membrane proteins (OMPs) (Raetz & Whitfield, 2002, Annual Review of Biochemistry). The LPS core glycolipid is a conserved region that maintains the structural integrity of the membrane and acts as a permeability barrier against toxic compounds, including many antibiotics (Nikaido, 2003, Microbiology and Molecular Biology Reviews). OMPs, such as porins and the BAM complex, are critical for nutrient acquisition and the proper assembly of the cell envelope (Knowles et al., 2009, Nature Reviews Microbiology). In the context of disease, LPS acts as a potent endotoxin, triggering an overactive immune response that can lead to life-threatening sepsis and septic shock (Opal, 2010, Journal of Infectious Diseases). Therapeutic agents targeting these components include polymyxins, which disrupt the membrane by binding to LPS, and novel inhibitors like murepavadin that target OMP-related transport systems (Landman et al., 2008, Clinical Microbiology Reviews; Martin-Loeches et al., 2018, Expert Opinion on Investigational Drugs). These targets are of high clinical importance for addressing multi-drug resistant Gram-negative pathogens.

Other names
Gram-negative bacterial outer membraneEndotoxin and surface proteinsLPS-OMP complexBacterial outer membrane components
02

Mechanism of action

Disruption of the bacterial outer membrane through binding to lipopolysaccharides; inhibition of outer membrane protein assembly via the BAM complex; inhibition of lipopolysaccharide transport via the Lpt pathway; neutralization of endotoxin-induced inflammatory responses.

03

Biological functions

Membrane integrityPermeability barrierEndotoxin activityProtein transport and assemblyNutrient and drug transport
04

Disease associations

Gram-negative bacterial infectionSepsisSeptic shockPneumoniaUrinary tract infection
05

Safety considerations

NephrotoxicityNeurotoxicityJarisch-Herxheimer reactionDevelopment of antimicrobial resistance
06

Interacting drugs

Polymyxin B

6 more in the full profile.

07

Biomarkers

Serum endotoxin levelsProcalcitoninC-reactive proteinBacterial load

Beyond the preview

Go deeper on Lipopolysaccharide core glycolipid and outer membrane proteins (LPS/OMP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipopolysaccharide core glycolipid and outer membrane proteins (LPS/OMP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call